What's new? Log in Free sign up

Guardion Health Sciences (GHSI) News and press releases

Company Profile

News

From Benzinga Pro

Guardion Health Sciences Q1 EPS $0.42 Up From $(3.50) YoY, Sales $3.19M Up From $2.38M YoY

Guardion Health Sciences (NASDAQ:GHSI) reported quarterly earnings of $0.42 per share. This is a 112 percent increase over losses of $(3.50) per share from the same period last year. The company reported $3.19 million

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Stocks That Hit 52-Week Lows On Monday

On Monday, 198 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Friday

On Friday, 497 companies set new 52-week lows.

Benzinga Pro's Top 5 Stocks To Watch For Monday, March 6, 2023: JD, GE, CIEN, GHSI, ALBT

Pre-Market Outlook

JD.com (JD) - China's second-largest retailer behind Alibaba (BABA). JD will report quarterly results on Thursday before market open. General Electric (GE) - The company

Press releases

From Benzinga Pro

Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023

Earnings, Press Releases

HOUSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) ("Guardion" or the "Company"), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022

Earnings, Press Releases

HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) ("Guardion" or the "Company"), a clinical nutrition company that offers a portfolio of science-based, clinically-supported

Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value

News, Management, Press Releases

HOUSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) ("Guardion" or the "Company"), a clinical nutrition company that offers a portfolio of science-based, clinically-supported

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.